Systematic review / meta-analysis / 2021
Milk consumption was associated with lower risk of multiple conditions including CVD and obesity, but higher risk of prostate cancer and Parkinson's disease.
An umbrella review examined 41 meta-analyses with 45 unique health outcomes in humans to evaluate the evidence on milk intake. Dose-response analyses indicated that a 200 ml per day increment in milk intake was linked to a lower risk of cardiovascular disease, stroke, hypertension, colorectal cancer, metabolic syndrome, obesity, and osteoporosis, with beneficial associations also observed for type 2 diabetes mellitus and Alzheimer's disease. Conversely, milk intake was associated with a higher risk of prostate cancer, Parkinson's disease, acne, and iron-deficiency anemia in infancy, with caution noted for potential allergy or lactose intolerance.
Shows an association, not proof of cause and effect.
- Study type
- Umbrella review of systematic reviews and meta-analyses
- Who was studied
- Humans across 41 meta-analyses evaluating 45 unique health outcomes
- What was measured
- Multiple health-related outcomes including CVD, cancer, diabetes, and others
THE PAPER
Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans.
Zhang X, Chen X, Xu Y, Yang J, Du L, Li K, Zhou Y. Nutr Metab (Lond), 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.